Approximately 72% of Medicare beneficiaries have at least 2 chronic medical conditions (most often diabetes, heart disease, and asthma/COPD), and roughly 40% have 4 or more.
Diabetes
Latest News
Advertisement
CME Content
Advertisement
Top articles of the week from The American Journal of Pharmacy Benefits.
Alternative treatment options to control blood glucose level in patients with type 2 diabetes show promise.
Novel treatment may prevent patients with type 1 diabetes from developing end-stage renal disease.
A dose of insulin 3 hours after eating may prevent blood vessel damage among patients with type 1 diabetes.
Top news of the day from across the health care landscape.
Patients with type 2 diabetes who do not take insulin may not require fingerstick testing.
Top news of the day from across the healthcare landscape.
Type 2 diabetes could result from beta cells becoming immature and not properly functioning.
Adding an investigational diabetes drug to anti-cancer regimen may reduce cardiotoxicity.
Top news of the day from across the health care landscape.
Gray market diagnostic OTC medical devices pose substantial health and safety risks to patients.
Top articles of the week from The American Journal of Pharmacy Benefits.
Eighty percent of patients with diabetes have uncontrolled blood sugars, blood pressures, or cholesterol.
The Journal of Continuing Education in the Health Professions has published a study that assessed the effect of interprofessional education (IPE) on the quality of diabetes care.
The discussions at the Advisory Committee meeting were based on data from the LEADER trial.
Efficacy of empagliflozin (Jardiance) may be limited to clinical trial population.
Top news of the day from across the health care landscape.
Functional high-intensity training may benefit patients with type 2 diabetes.
Experimental biopolymer observed to maintain blood glucose levels in monkeys for 2 weeks.
Pharmacists help underserved adults with uncontrolled type 2 diabetes who live in rural areas.
A telemedicine diabetes program was well received by patients and effective at improving patient outcomes, according to a study published online in the North Carolina Medical Journal.
Top news of the day from across the health care landscape.
BioChaperone Combo integrates Lantus and Humalog.
This article highlights 5 published case reports that document unusual drug overdoses.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
2
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
3
In 2026, Pharmacists Will Be Driving Change Across the Care Continuum
4
AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer
5